Linda Brecher, DO
Rheumatology · Stratford, NJNPI 1346297215
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,400 of the $8,381 with a category attached, or 64.4%. Lilly USA, LLC accounts for 90.3% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $7,797 and has fallen 98.4% since, to $125 in 2024.
Across 39 payments — averaging $214.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$8K
- AstraZeneca$250
- Aurinia Pharma U.S., Inc.$213
- GSK$123
- Amgen$55
- Genentech, Inc.$40
- plus $135 from 7 others
What the payments were for
- Consulting fees$1,57519%
- Speaking & faculty fees$5,40064%
- Travel & lodging$4295%
- Food & beverage$93611%
- Education$410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 18 | $7,565 |
| AstraZeneca(2 entities) | 2 | $250 |
| Aurinia Pharma U.S., Inc. | 2 | $213 |
| GSK | 2 | $123 |
| Amgen | 4 | $55 |
| Genentech, Inc. | 1 | $40 |
| Novartis | 2 | $32 |
| Pfizer | 2 | $25 |
| Johnson & Johnson(2 entities) | 2 | $23 |
| Novo Nordisk | 1 | $16 |
| UCB, Inc. | 1 | $15 |
| Boston Scientific | 1 | $13 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,381 in reported general payments places this provider in the 75th percentile of 234 rheumatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 21 | $141,211 |
| Enbrel SureclickEtanercept | 18 | $128,811 |
| SimponiGolimumab | 19 | $117,416 |
| RinvoqUpadacitinib | 12 | $72,884 |
| Teriparatide | 12 | $40,462 |
| ProliaDenosumab | 17 | $29,099 |
| Hydroxychloroquine Sulfate | 106 | $4,503 |
| MethotrexateMethotrexate Sodium | 68 | $2,445 |
| Mycophenolic AcidMycophenolate Sodium | 12 | $2,111 |
| Alendronate Sodium | 14 | $1,321 |
| Risedronate Sodium | 31 | $1,223 |
| Duloxetine Hcl | 32 | $908 |
| Sulfasalazine DrSulfasalazine | 21 | $748 |
| Prednisone | 95 | $652 |
| Gabapentin | 25 | $399 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSimponi | $23 | $117,41619 claims |
| AmgenProlia | $55 | $29,09917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 234 rheumatology providers in New Jersey.
Other rheumatology in Stratford
- Lori CoxNew Brunswick$1.4M
- Richard HaddadRed Bank$1.1M
- Kiren SahniWest Long Branch$569K
- Jeffrey GreenbergSummit$399K
- Steven GolombekDover$318K
- Nicholas ScarpaJersey City$281K
- Adrienne HollanderVoorhees$214K
- Edward AllegraRed Bank$212K
- Nickolas TyrisSewell$201K
- Anan HaijaGalloway$196K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.